Taizo Hirata

Hiroshima, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer.

Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer.

Journal: Journal of thoracic disease
Published: December 07, 2023

A Multicenter, Open-Label, Single-Arm Phase I Trial of Dual-Wield Parenchymal Transection: A New Technique of Liver Resection Using the Cavitron Ultrasonic Surgical Aspirator and Water-Jet Scalpel Simultaneously (HiSCO-14 Trial).

A Multicenter, Open-Label, Single-Arm Phase I Trial of Dual-Wield Parenchymal Transection: A New Technique of Liver Resection Using the Cavitron Ultrasonic Surgical Aspirator and Water-Jet Scalpel Simultaneously (HiSCO-14 Trial).

Journal: Cureus
Published: November 18, 2023

Protection From Second Warm Ischemic Injury Using a Thermal Barrier Bag in Kidney Transplantation.

Protection From Second Warm Ischemic Injury Using a Thermal Barrier Bag in Kidney Transplantation.

Journal: Transplantation direct
Published: December 22, 2022

Adoptive immunotherapy with natural killer cells from peripheral blood CD34+ stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study.

Adoptive immunotherapy with natural killer cells from peripheral blood CD34+ stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study.

Journal: BMJ open
Published: November 21, 2022

Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin.

Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin.

Journal: Internal medicine (Tokyo, Japan)
Published: July 31, 2022

A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.

A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.

Journal: Internal medicine (Tokyo, Japan)
Published: November 16, 2020

Primary cardiac rhabdomyosarcoma successfully treated with eribulin: a case report.

Primary cardiac rhabdomyosarcoma successfully treated with eribulin: a case report.

Journal: Anti-cancer drugs
Published: November 15, 2019

Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.

Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 30, 2019

Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.

Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.

Journal: World journal of surgical oncology
Published: September 05, 2018

Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer.

Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer.

Journal: Oncotarget
Published: April 04, 2018

A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non-Small Cell Lung Cancer.

A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non-Small Cell Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 10, 2017

A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment following disease progression during anthracycline-based neoadjuvant chemotherapy.

A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment following disease progression during anthracycline-based neoadjuvant chemotherapy.

Journal: International journal of surgery case reports
Published: May 26, 2017
Showing 1-12 of 33

Last Updated: 09/26/2026